Heba Alshater
Heba Alshater publishes mostly in Organic Chemistry, Materials Chemistry and Oncology, on topics such as Metal complexes synthesis and properties, Synthesis and biological activity and Synthesis and Characterization of Heterocyclic Compounds.
- World rank
- #1,834,469 of 7,710,434 ranked researchers
- Rank in Egypt
- #4,862 of 36,277
- Works
- 49
- Citations
- 531
- Citations per work
- 10.8
What does Heba Alshater research?
Heba Alshater's work is mostly in Chemistry (19%), Materials Science (18%), Medicine (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2245.3%
- Physical Sciences2143.0%
- Chemistry918.6%
- Materials Science917.6%
- Energy23.9%
- Engineering12.9%
- Health Sciences47.8%
- Medicine47.8%
- Life Sciences23.9%
- 1Organic Chemistry19% of their works
- 2Materials Chemistry18% of their works
- 3Oncology8% of their works
- 4Renewable Energy, Sustainability and the Environment4% of their works
- 5Molecular Biology4% of their works
- 6Electrical and Electronic Engineering3% of their works
Research topics
- Metal complexes synthesis and properties
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
- Free Radicals and Antioxidants
- Nanoparticles: synthesis and applications
- Computational Drug Discovery Methods
- Phytochemistry and biological activity of medicinal plants
- Crystal structures of chemical compounds
Which keywords describe Heba Alshater's research?
The keywords of their largest research topics: Anticancer Agents, Antimicrobial, Cisplatin Resistance, Medicinal Chemistry, Platinum-Based Drugs, Molecular Docking, Anticancer and Antioxidant.
- Emodin
- Aloe Vera
- Drug Target Identification
- Synthesis
- Radical Scavenging
- Nanoparticles
- Heterocyclic Compounds
- Antioxidant
- Molecular Docking
- Medicinal Chemistry
- Antimicrobial
- Anticancer Agents
- Cisplatin Resistance
- Platinum-Based Drugs
- Anticancer
- Toxicity
- Tubulin Inhibitors
- Phenolic Compounds
- Silver
- Triazines
- Virtual Screening
- Crystal Structure Refinement
- Hirshfeld Surface Analysis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- Anticancer Agents132 topics
- Antimicrobial82 topics
- Cisplatin Resistance81 topic
- Medicinal Chemistry82 topics
- Platinum-Based Drugs81 topic
- Molecular Docking72 topics
- Anticancer62 topics
- Antioxidant62 topics
- Toxicity62 topics
- Heterocyclic Compounds51 topic
- Tubulin Inhibitors51 topic
- Nanoparticles41 topic
- Phenolic Compounds41 topic
- Radical Scavenging41 topic
- Silver41 topic
- Synthesis41 topic
- Triazines41 topic
- Drug Target Identification31 topic
- Virtual Screening31 topic
- Aloe Vera21 topic
- Crystal Structure Refinement21 topic
- Emodin21 topic
- Hirshfeld Surface Analysis21 topic
Where does Heba Alshater work?
Heba Alshater's main affiliation in the publication record is Menoufia University, Egypt.
How many publications and citations does Heba Alshater have?
OpenAlex counts 49 works and 531 citations for Heba Alshater, an h-index of 13, ranking #1,834,469 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Heba Alshater. Posts are plain text and can be reported.